Kineta Inc KA:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
Last | 05/23/24 EDT
0.451UNCH (UNCH)
Volume
24,824
52 week range
0.33 - 5.39
Loading...
  • Open0.4758
  • Day High0.4758
  • Day Low0.44
  • Prev Close0.4758
  • 52 Week High5.39
  • 52 Week High Date10/03/23
  • 52 Week Low0.33
  • 52 Week Low Date04/16/24

Key Stats

  • Market Cap5.527M
  • Shares Out12.25M
  • 10 Day Average Volume0.11M
  • Dividend-
  • Dividend Yield-
  • Beta-0.21
  • YTD % Change-87.11

KEY STATS

  • Open0.4758
  • Day High0.4758
  • Day Low0.44
  • Prev Close0.4758
  • 52 Week High5.39
  • 52 Week High Date10/03/23
  • 52 Week Low0.33
  • 52 Week Low Date04/16/24
  • Market Cap5.527M
  • Shares Out12.25M
  • 10 Day Average Volume0.11M
  • Dividend-
  • Dividend Yield-
  • Beta-0.21
  • YTD % Change-87.11

RATIOS/PROFITABILITY

  • EPS (TTM)-1.55
  • P/E (TTM)-0.29
  • Fwd P/E (NTM)-0.50
  • EBITDA (TTM)-15.636M
  • ROE (TTM)-385.53%
  • Revenue (TTM)5.161M
  • Gross Margin (TTM)-
  • Net Margin (TTM)-345.77%
  • Debt To Equity (MRQ)-12.17%

EVENTS

  • Earnings Date08/09/2024(est)
  • Ex Div Date12/19/2022
  • Div Amount10.01
  • Split Date-
  • Split Factor-

Latest On Kineta Inc

 

Profile

MORE
Kineta, Inc. is a clinical-stage biotechnology company. The Company has leveraged its expertise in innate immunity and is focused on discovering and developing potentially differentiated immunotherapies that address the mechanisms of cancer immune resistance: immunosuppression, exhausted T cells and poor tumor immunogenicity. Its pipeline of immunotherapies includes KVA12123, which is a monoclonal antibody (mAb), immunotherapy targeting VISTA (V-domain Ig suppressor of T cell...
Craig Philips
President
Keith Baker
Chief Financial Officer
Jacques Bouchy
Executive Vice President - Investor Relations and Business Development
Address
7683 Se 27Th Street, Suite 481
Mercer Island, WA
98040
United States

Top Peers

SYMBOLLASTCHG%CHG
PULM
Pulmatrix Inc
1.90UNCHUNCH
BLPH
Bellerophon Therapeutics Inc
0.0563UNCHUNCH
ATHXQ
Athersys Inc
0.0046-0.0001-2.5263%
SCPX
Scorpius Holdings Inc
0.1042UNCHUNCH
OPGN
OpGen Inc
3.27UNCHUNCH